Patents by Inventor Anders Näär

Anders Näär has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11136291
    Abstract: Provided herein are compounds (e.g., compounds of Formulae (I), (II), and (III)) which are anti-fungal agents and can be used in the treatment of diseases, including infectious diseases. The invention provides methods of treating diseases in a subject (e.g., infectious diseases such as fungal infections), and methods of killing or inhibiting the growth of fungi in or on a subject or biological sample. The compounds may be used in subjects, in clinical settings, or in agricultural settings.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: October 5, 2021
    Assignees: Dana-Farber Cancer Institute, Inc., Centre Hospitalier Universitaire Vaudois, The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Sara Jean Buhrlage, Anders Näär, Gerhard Wagner, Haribabu Arthanari, Joy Luz Nishikawa, Andras Pal Boeszoermenyi, Dominique Sanglard
  • Publication number: 20210147351
    Abstract: Provided herein are compounds (e.g., compounds of Formulae (I), (II), and (III)) which are anti-fungal agents and can be used in the treatment of diseases, including infectious diseases. The invention provides methods of treating diseases in a subject (e.g., infectious diseases such as fungal infections), and methods of killing or inhibiting the growth of fungi in or on a subject or biological sample. The compounds may be used in subjects, in clinical settings, or in agricultural settings.
    Type: Application
    Filed: February 17, 2017
    Publication date: May 20, 2021
    Applicants: Dana-Farber Cancer Institute, Inc., Centre Hospitalier Universitaire Vaudois, President and Fellows of Harvard College, The General Hospital Corporation
    Inventors: Sara Jean Buhrlage, Anders Näär, Gerhard Wagner, Haribabu Arthanari, Joy Luz Nishikawa, Andras Pal Boeszoermenyi, Dominique Sanglard
  • Publication number: 20200140381
    Abstract: Provided herein are compounds (e.g., compounds of Formulae (I), (II), and (III)) which are anti-fungal agents and can be used in the treatment of diseases, including infectious diseases. The invention provides methods of treating diseases in a subject (e.g., infectious diseases such as fungal infections), and methods of killing or inhibiting the growth of fungi in or on a subject or biological sample. The compounds may be used in subjects, in clinical settings, or in agricultural settings.
    Type: Application
    Filed: February 17, 2017
    Publication date: May 7, 2020
    Applicants: Dana-Farber Cancer Institute, Inc., Centre Hospitalier Universitaire Vaudois, President and Fellows of Harvard College, The General Hospital Corporation
    Inventors: Sara Jean Buhrlage, Anders Näär, Gerhard Wagner, Haribabu Arthanari, Joy Luz Nishikawa, Andras Pal Boeszoermenyi, Dominique Sanglard